Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan

被引:66
作者
Takada, Norikata [1 ]
Abe, Takashige [1 ]
Shinohara, Nobuo [1 ]
Sazawa, Ataru [1 ]
Maruyama, Satoru [1 ]
Shinno, Yuichiro [2 ]
Sato, Soshu [2 ]
Mitsuhashi, Kimiyoshi [2 ]
Sato, Takuya [2 ]
Sugishita, Keiji [2 ]
Kamota, Shinji [2 ]
Yamashita, Takanori [2 ]
Ishizaki, Junji [2 ]
Hioka, Takaya [2 ]
Mouri, Gaku [2 ]
Ono, Takenori [2 ]
Miyajima, Naoto [2 ]
Sakuta, Takanori [2 ]
Mochizuki, Tango [2 ]
Aoyagi, Toshiki [2 ]
Katano, Hidenori [2 ]
Akino, Tomoshige [2 ]
Hirakawa, Kazushi [2 ]
Minami, Keita [2 ]
Kumagai, Akira [2 ]
Seki, Toshimori [2 ]
Togashi, Masaki [2 ]
Nonomura, Katsuya [1 ]
机构
[1] Hokkaido Univ, Dept Urol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Urothelial Canc Res Grp, Sapporo, Hokkaido, Japan
关键词
complication; radical cystectomy; morbidity; mortality; INVASIVE BLADDER-CANCER; NEOADJUVANT CHEMOTHERAPY; CONTEMPORARY SERIES; RISK-FACTORS; HEALTH-CARE; COMPLICATIONS; OUTCOMES; MULTICENTER; POPULATION; ASSOCIATION;
D O I
10.1111/j.1464-410X.2012.11609.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine the type, incidence and severity of 90-day morbidity after radical cystectomy in our institution and our affiliated hospitals in accordance with a standard reporting methodology. At present, most studies on complications associated with open radical cystectomy are derived from Western academic high-volume centres and data from Japan and other Asian countries remain very limited. PATIENTS AND METHODS The study comprised a retrospective multi-institutional study. The records were reviewed of 928 patients who underwent open radical cystectomy between 1997 and 2010. All complications within 90 days of surgery were categorized into 11 specific categories and graded in accordance with the modified Clavien system. Multivariate regression models were used to determine predictors of complications. RESULTS At least one complication was observed in 635 (68%) patients and a major (grade 3-5) complication was observed in 156 (17%) patients. The most common complication categories were infectious (30%), gastrointestinal (26%), wound-related (21%) and genitourinary (15%). The 30-day mortality rate was 0.8% and the 90-day mortality rate was 2%. A multivariate regression model showed that previous cardiovascular comorbidity and type of urinary diversion (i.e. ileal conduit or neobladder) were significant factors for any and major complications. CONCLUSIONS Surgical complication-related radical cystectomy is significant and both previous cardiovascular comorbidity and the type of urinary diversion were found to be significant factors for any and major complications. The 90-day mortality rate was 2%, which is compatible with reports from Western high-volume centres.
引用
收藏
页码:E756 / E764
页数:9
相关论文
共 30 条
  • [1] Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
    Abol-Enein, H
    Bassi, P
    Boyer, M
    Coppin, CML
    Cortesi, E
    Grossman, HB
    Hall, RR
    Horwich, A
    Malmström, PU
    Martinez-Piñeiro, JA
    Sengelov, L
    Sherif, A
    Wallace, DMA
    Bono, AV
    Goebell, PJ
    Groshen, S
    Torti, FM
    Clarke, NW
    Roberts, JT
    Sylvester, R
    Parmar, MKB
    Stewart, LA
    Tierney, JF
    Vale, CL
    [J]. EUROPEAN UROLOGY, 2005, 48 (02) : 202 - 206
  • [2] Association of procedure volume with radical cystectomy outcomes in a nationwide database
    Barbieri, Christopher E.
    Lee, Byron
    Cookson, Michael S.
    Bingham, John
    Clark, Peter E.
    Smith, Joseph A., Jr.
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (04) : 1418 - 1421
  • [3] Risk factors for mortality and morbidity related to radical cystectomy
    Bostrom, Peter J.
    Kossi, Jyrki
    Laato, Matti
    Nurmi, Martti
    [J]. BJU INTERNATIONAL, 2009, 103 (02) : 191 - 196
  • [4] Analysis of early complications after radical cystectomy: Results of a collaborative care pathway
    Chang, SS
    Cookson, MS
    Baumgartner, RG
    Wells, N
    Smith, JA
    [J]. JOURNAL OF UROLOGY, 2002, 167 (05) : 2012 - 2016
  • [5] A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder A Retrospective Experience
    Dash, Atreya
    Pettus, Joseph A.
    Herr, Harry W.
    Bochner, Bernard H.
    Dalbagni, Guido
    Donat, S. Machele
    Russo, Paul
    Boyle, Mary G.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. CANCER, 2008, 113 (09) : 2471 - 2477
  • [6] Standards for surgical complication reporting in urologic oncology: Time for a change
    Donat, Sherri Machele
    [J]. UROLOGY, 2007, 69 (02) : 221 - 225
  • [7] Enhanced recovery after surgery: A consensus review of clinical care for patients undergoing colonic resection
    Fearon, KCH
    Ljungqvist, O
    Von Meyenfeldt, M
    Revhaug, A
    Dejong, CHC
    Lassen, K
    Nygren, J
    Hausel, J
    Soop, M
    Andersen, J
    Kehlet, H
    [J]. CLINICAL NUTRITION, 2005, 24 (03) : 466 - 477
  • [8] Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
    Grossman, HB
    Natale, RB
    Tangen, CM
    Speights, VO
    Vogelzang, NJ
    Trump, DL
    White, RWD
    Sarosdy, MF
    Wood, DP
    Raghavan, D
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) : 859 - 866
  • [9] Lessons Learned From 1,000 Neobladders: The 90-Day Complication Rate
    Hautmann, Richard E.
    de Petriconi, Robert C.
    Volkmer, Bjoern G.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (03) : 990 - 994